Zobrazeno 1 - 3
of 3
pro vyhledávání: '"María Aranzazu Ortega-Pozzi"'
Autor:
Noemi Ramos-López, Carlos Ferrera, Tania Luque, Daniel Enríquez-Vázquez, Patricia Mahía-Casado, Laura Galván-Herráez, José María Pedrajas, Pablo Salinas, Francisco Javier Noriega, Pablo Zulet Fraile, Fabián Islas, Carlos Real, Hernán Mejía-Rentería, Pilar Jiménez-Quevedo, Nieves Gonzalo, Iván Nuñez-Gil, Luis Nombela-Franco, Gabriela Tirado, Fernando Macaya, Javier Escaned, Ana María Mañas Hernández, José Bustamante, Mónica Pérez Serrano, Esther Bernardo García, María Aranzazu Ortega Pozzi, Javier Higueras, Alberto de Agustín, Ana Viana-Tejedor, Antonio Fernández-Ortiz
Publikováno v:
Medicina Clínica.
Autor:
David Vivas, José Julio Jiménez, Roberto Martín-Asenjo, Esther Bernardo, María Aranzazu Ortega-Pozzi, Juan Carlos Gómez-Polo, Guillermo Moreno, Isidre Vilacosta, Julián Pérez-Villacastín, Antonio Fernández-Ortiz
Publikováno v:
Journal of thrombosis and thrombolysis.
Prasugrel and ticagrelor, new P2Y12-ADP receptor antagonists, are associated with greater pharmacodynamic inhibition and reduction of cardiovascular events in patients with an acute coronary syndrome. However, evidence is lacked about the effects of
Autor:
Cristina Fernández, Gabriela Tirado, Isidre Vilacosta, Antonio Fernández-Ortiz, Carlos Macaya, David Vivas, María Aranzazu Ortega-Pozzi, Agustin Martin, Iván J. Núñez-Gil, Esther Bernardo
Publikováno v:
Circulation. Cardiovascular interventions. 8(5)
Background— Prasugrel and ticagrelor, new P2Y 12 -adenosine diphosphate receptor antagonists, are associated with greater pharmacodynamic inhibition and reduction of cardiovascular events compared with clopidogrel in patients with an acute coronary